Your browser doesn't support javascript.
loading
Coumaric acid derivatives as tyrosinase inhibitors: Efficacy studies through in silico, in vitro and ex vivo approaches.
Varela, Marina Themoteo; Ferrarini, Márcio; Mercaldi, Vitória Gallo; Sufi, Bianca da Silva; Padovani, Giovana; Nazato, Lucas Idacir Sbrugnera; Fernandes, João Paulo S.
Afiliação
  • Varela MT; Department of Pharmaceutical Sciences, Institute of Environmental, Chemical and Pharmaceutical Sciences, Universidade Federal de São Paulo, Rua São Nicolau 210, 09913-030 Diadema-SP, Brazil.
  • Ferrarini M; Department of Pharmaceutical Sciences, Institute of Environmental, Chemical and Pharmaceutical Sciences, Universidade Federal de São Paulo, Rua São Nicolau 210, 09913-030 Diadema-SP, Brazil.
  • Mercaldi VG; Department of Pharmaceutical Sciences, Institute of Environmental, Chemical and Pharmaceutical Sciences, Universidade Federal de São Paulo, Rua São Nicolau 210, 09913-030 Diadema-SP, Brazil.
  • Sufi BDS; Research and Development Department, Chemyunion Química Ltda, Av. Independência 1501, 18087-101 Sorocaba-SP, Brazil.
  • Padovani G; Research and Development Department, Chemyunion Química Ltda, Av. Independência 1501, 18087-101 Sorocaba-SP, Brazil.
  • Nazato LIS; Research and Development Department, Chemyunion Química Ltda, Av. Independência 1501, 18087-101 Sorocaba-SP, Brazil.
  • Fernandes JPS; Department of Pharmaceutical Sciences, Institute of Environmental, Chemical and Pharmaceutical Sciences, Universidade Federal de São Paulo, Rua São Nicolau 210, 09913-030 Diadema-SP, Brazil. Electronic address: joao.fernandes@unifesp.br.
Bioorg Chem ; 103: 104108, 2020 10.
Article em En | MEDLINE | ID: mdl-32750608
p-Coumaric acid is a known inhibitor of tyrosinase, an enzyme involved in the initial steps of the melanin synthesis in human and other species. However, its low lipophilicity impairs its penetration through skin and efficacy as antimelanogenic agent indeed. Accordingly, this paper reports the assessment of several coumaric acid derivatives as tyrosinase inhibitors and antimelanogenic agents in in vitro, in silico and ex vivo assays. The compounds were designed with modifications in the aromatic and acid moieties of p-coumaric acid, being the coumarate esters the most promising derivatives. The compounds showed higher tyrosinase inhibitory activity (pIC50 3.7-4.2) than the parent acid, being compounds 1d, 1e and 1f the most potent inhibitors. Docking analysis showed that these esters are competitive inhibitors per se, and act independently of a redox mechanism as suggested by DPPH assays. Moreover, the esters showed efficacy in reducing the melanin deposition in human skin fragments at 0.1% concentration, especially compound 1e. In summary, there is an important equilibria between tyrosinase affinity and lipophilicity that must be considered to get effective antimelanogenic agents with adequate permeability in the skin.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Monofenol Mono-Oxigenase / Ácidos Cumáricos / Inibidores Enzimáticos Limite: Humans Idioma: En Revista: Bioorg Chem Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Monofenol Mono-Oxigenase / Ácidos Cumáricos / Inibidores Enzimáticos Limite: Humans Idioma: En Revista: Bioorg Chem Ano de publicação: 2020 Tipo de documento: Article